Literature DB >> 30016457

Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers.

Annelies Wilder-Smith1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30016457     DOI： 10.1093/jtm/tay057

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  13 in total

Review 1.  Risk of Dengue in Travelers: Implications for Dengue Vaccination.

Authors:  Annelies Wilder-Smith
Journal:  Curr Infect Dis Rep       Date:  2018-10-29       Impact factor: 3.725

Review 2.  Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.

Authors:  Anna P Durbin
Journal:  Curr Opin Virol       Date:  2020-10-23       Impact factor: 7.090

3.  A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.

Authors:  Yesim Tozan; Tyler Y Headley; Maquines Odhiambo Sewe; Eli Schwartz; Tamar Shemesh; Jakob P Cramer; Kirsten A Eberhardt; Michael Ramharter; Nicole Harrison; Karin Leder; Andrea Angheben; Christoph Hatz; Andreas Neumayr; Lin Hwei Chen; Cornelis A De Pijper; Martin P Grobusch; Annelies Wilder-Smith
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

Review 4.  Vaccines and Senior Travellers.

Authors:  Fiona Ecarnot; Stefania Maggi; Jean-Pierre Michel; Nicola Veronese; Andrea Rossanese
Journal:  Front Aging       Date:  2021-07-09

5.  Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium.

Authors:  Annelies Wilder-Smith; Hasitha Tissera; Sazaly AbuBakar; Pattamaporn Kittayapong; James Logan; Andreas Neumayr; Joacim Rocklöv; Peter Byass; Valérie R Louis; Yesim Tozan; Eduardo Massad; Raman Preet
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

6.  Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

Authors:  Guido España; Yutong Yao; Kathryn B Anderson; Meagan C Fitzpatrick; David L Smith; Amy C Morrison; Annelies Wilder-Smith; Thomas W Scott; T Alex Perkins
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01

Review 7.  Dengue vaccine development: status and future.

Authors:  Annelies Wilder-Smith
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-01       Impact factor: 1.513

8.  Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews.

Authors:  R Luo; N Fongwen; C Kelly-Cirino; E Harris; A Wilder-Smith; R W Peeling
Journal:  Clin Microbiol Infect       Date:  2019-01-18       Impact factor: 8.067

Review 9.  Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Authors:  Iris Valdés; Laura Lazo; Lisset Hermida; Gerardo Guillén; Lázaro Gil
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

10.  Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.

Authors:  Humberto Reynales; Gabriel Carrasquilla; Betzana Zambrano; Margarita Cortés S; Tifany Machabert; Jin Jing; Sophie Pallardy; Owen Haney; Martha Faccini; Juliana Quintero; Fernando Noriega
Journal:  Pediatr Infect Dis J       Date:  2020-04       Impact factor: 3.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.